[Choice of proton pump inhibitors--does it play any role?].
Hellström
Per M
PM
Kliniken för gastroenterologi och hepatologi, Karolinska Universitetssjukhuset Solna, SE-171 76 Stockholm. per.hellstrom@medks.ki.se
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D001562:Benzimidazoles / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D016568:Drugs, Generic / Q000008:administration & dosage*; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D013454:Sulfoxides / Q000008:administration & dosage
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D016568:Drugs, Generic; D054328:Proton Pump Inhibitors; D013454:Sulfoxides; D064747:Lansoprazole; D064750:Rabeprazole; D000077402:Pantoprazole; D009853:Omeprazole